Patents by Inventor Gotz Laible

Gotz Laible has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chromatin regulator genes
    Patent number: 7252968
    Abstract: The invention concerns the deregulation of the chromatin-regulator genes which have a SET domain, such deregulation being of importance in certain cancer conditions. These genes can be used in the diagnosis and therapy of such conditions.
    Type: Grant
    Filed: February 9, 2004
    Date of Patent: August 7, 2007
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Jenuwein, Götz Laible, Donal O'Carroll, Frank Eisenhaber, Stephen Rea
  • Chromatin regulator genes
    Publication number: 20050089880
    Abstract: The invention concerns the deregulation of the chromatin-regulator genes which have a SET domain, such deregulation being of importance in certain cancer conditions. These genes can be used in the diagnosis and therapy of such conditions.
    Type: Application
    Filed: February 9, 2004
    Publication date: April 28, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Thomas Jenuwein, Gotz Laible, Donal O'Carroll, Frank Eisenhaber, Stephen Rea
  • Chromatin regulator genes
    Patent number: 6689583
    Abstract: The invention concerns the deregulation of the chromatin-regulator genes which have a SET domain, such deregulation being of importance in certain cancer conditions. These genes can be used in the diagnosis and therapy of such conditions.
    Type: Grant
    Filed: June 9, 2000
    Date of Patent: February 10, 2004
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Jenuwein, Götz Laible, Donal O'Carroll, Frank Eisenhaber, Stephen Rea